VIP (Vasoactive Intestinal Peptide) — Indexed Studies

Early Intervention with Calcineurin Inhibitors in Paediatric Segmental Vitiligo: A Retrospective Case Series.

Paganelli A, Scaglione GL, Di Lernia VG et al.

Development and validation of an Arabic vitiligo impact patient scale short form version.

Atwa MA, Alkhowailed MS, Abdallah M et al.

Quality of life assessment in vitiligo patients: a cross-sectional study.

Simões NMN, Franciscatti GC, Froes Junior LAR et al.

Comment on "Efficacy and Safety of Combined Platelet-Rich Plasma With Fractional Laser for Adult Patients With Vitiligo: A Systematic Review and Meta-Analysis of Randomized Controlled Trials".

Pavlović MD

A Case Series of Tofacitinib Treatment for Chronic Spontaneous Urticaria with Inadequate Response to Omalizumab.

Zhang X, Zhu M, Ye Y

Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis.

Alzahrani D, Niaz G, Roblah TM et al.

Immunotherapy-induced vitiligo and demyelinating plaques: a case report suggesting a neurocutaneous mechanism.

Ersivri D, Hayber E, Yazar U et al.

A Study of Cutaneous Manifestations in Patients During the Post-COVID Period in A Tertiary Care Center.

Pandey A, Ashtekar RS, Tippanawar SA et al.

Treatment of Refractory Nonsegmental Pediatric Vitiligo With Upadacitinib and NB-UVB: A Case Report.

Liu P, Jianjun Q, Deng Q

Evaluating the usefulness of ChatGPT and Gemini in generating educational content for patients with vitiligo: a comparative cross-sectional study.

Tamer F, Polat M

UV Protection Habits and Preferences in Patients With Distinct Cutaneous Immune-Mediated Inflammatory Diseases.

Bobillo ZÁ, Urrutia IB, Cazaña TG et al.

Oral JAK Inhibitors in Pediatric Generalized Vitiligo Resistant to Conventional Treatment: A Case Series.

Vidal González A, Escudero Tornero R, López Alcázar S et al.

Prolonged ruxolitinib cream treatment for vitiligo among patients with no or limited response in the first 6 months.

Wolkerstorfer A, Gooderham MJ, Sebastian M et al.

The clinical and multimodal imaging features of IgG4-related dacryoadenitis with coexisting vitiligo: A case report.

Tian T, Feng L

Efficacy of Topical 5-Fluorouracil Combined with Microneedling in the Treatment of Stable Vitiligo.

Abdulqader NMB, Qurtas DS, Sharaf BK

Topical Ruxolitinib Therapy Decreases Rates of Depression and Anxiety: A Retrospective Analysis in Vitiligo Patients.

Cherradi R, Ahuja R, Nezafati K

Associated comorbidities in pediatric patients with alopecia areata.

Martínez-Gayosso A, García-Romero MT

Early onset, genital, and axillary involvement are strongly associated with impaired quality of life in hyperhidrosis patients.

AbuDujain NM, Alrodiman Y, Allabboudy L et al.

VKH-Like Syndrome in a Patient on Tofacitinib.

Tran JH, Hosseini H, Tsui E et al.

Evaluation of Helicobacter pylori infection and clinical features in multiple sclerosis patients coexisting with vitiligo: Case-series.

Aghaei M, Aghaei S, Shahmoradi Z et al.

Increased Risk of Sensorineural Hearing Loss in Patients with Vitiligo: A Nested Case-Control Study.

Vaidyula VR, Kundu RV

Correction: Vitiligo associated with ribociclib therapy: a rare case report.

Wang Z, Bai Y, Wu R et al.

Defining Important Aspects of Repigmentation in Vitiligo: Insights From Patients' Perspectives.

Duponselle J, Jukema MR, van Buchem-Post N et al.

Microneedling combined with different topically applied medications in treatment of vitiligo patients.

Nazmy NN, Sorour NE, Abdullah EAI et al.

miR-19a-3p accelerates the development of melanoma and reduces the prognosis of patients.

Kang T, Xu L, Wang G

Insights into pediatric epilepsy and systemic autoimmune disorders: A study using the national inpatient database.

Alyoubi R, Abu-Zaid A

Hidden burden of non-exposed vitiligo: Psychological and quality of life impact in 283 patients.

Ju HJ, Bang YS, Shin JH et al.

Neutral Lipid Storage Disease with Myopathy: A Case Report with a Novel PNPLA2 Mutation.

Desai S, Shah A, Neelamegam S et al.

Three-dimensional imaging for facial vitiligo: Results from a phase 2 randomized controlled trial investigating upadacitinib in patients with vitiligo.

Ganesan AK, Ezzedine K, Hanna S et al.

Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial.

Hoeijmakers LL, Dimitriadis P, Wijnen SCMA et al.

Ocular and auditory associations in patients with vitiligo: A single-center retrospective study of 8512 patients.

Jing FZ, Bahr TA, Todd A et al.

Co-Occurrence of Inflammatory Bowel Disease in Patients with Vitiligo: A Systematic Review and Meta-Analysis.

Gu Z, Teng J

Case Report: Pembrolizumab associated lichen planus in early stage triple negative breast cancer.

Buyukahisha O, Ozcelik A, Baycelebi D et al.

Emergence of Vitiligo during Treatment with Risankizumab-Rzaa for Plaque Psoriasis: A Case Report.

Thomas KV, Tran JM, Cotter LM

Extraintestinal Cutaneous Manifestations in Inflammatory Bowel Disease Among Non-White Patients: A Retrospective Multicenter Study.

Ailawadi S, Sethi S, Mahmood A et al.

Elevated Risk of Herpes Zoster in Vitiligo Patients: A Nationwide Population-Based Cohort Study of Taiwan.

Lin BS, Chung CH, Weng TH et al.

Evaluation of Oxidative Stress in Red Blood Cells From Vitiligo Patients and Its Correlation With Disease Severity and Activity: A Cohort Case-Control Study.

Saleh YSN, Mohammed GF, Anani M et al.

Halo Seborrheic Keratosis in a Patient of Color With Vitiligo.

Nwaopara A, Burgess CM

Real-Life Perception of Treatment Effectiveness After 24 Weeks of Topical Ruxolitinib in Non-Segmental Vitiligo: Insights From Patient-Reported Outcomes.

Alberti-Violetti S, Tavoletti G, Del Signore F et al.

Knowledge, Attitude, and Behavior of Photoprotection in Thai Vitiligo Patients.

Wongpraparut O, Wannawittayapa T, Wattanasillawat P et al.

Surgical Treatment of Stable Vitiligo: A Case Series of Autologous Non-Cultured Epidermal Cellular Grafting Using a Modified Protocol.

Islam R, Doolan BJ, Kok C et al.

Association Between Topical Ruxolitinib Treatment and Psychiatric Outcomes in Adults With Vitiligo.

Sidhu K, Verma K, Kapur S et al.

Combining bioinformatics prediction with experimental validation to explore the ameliorative effect of Psoralea corylifolia on vitiligo.

Zhang C, Cao Z, Wei M et al.

Correction to "Type I Interferons Induce CD8(+) T Cell Chemotaxis Through Regulating Melanocyte but Not Keratinocyte CXCL9/10/11 Secretion in the Initiation of Vitiligo".

Combination Therapy with 308-nm Excimer Laser, Compound Glycyrrhizin, and Tacrolimus for Pediatric Facial and Cervical Vitiligo.

Qian Y, Wu Y, Li W et al.

Curcumin for The Management of Skin Diseases: A Review of the Results of Preclinical and Clinical Trials and Nanoformulations.

Sivamaruthi BS, Suganthy N, Chaiyasut C et al.

Editorial: Exploring pigmentary disorders: pathogenesis to treatment.

Thakur V, Narayan R V

Impact of Autoimmune Disease on Outcomes After Total Thyroidectomy for Thyrotoxicosis.

Arain HA, Swaminathan N, Caretti R et al.

Unanchored by two hits: IFNγ and mechanical stress synergize to undermine melanocyte adhesion and promote vitiligo.

Lee EJ, Kwon IJ, Kim JY et al.

Psychiatric Associations of Vitiligo by Race: A Retrospective Cohort Analysis Using a Large Multicenter Database.

Pathak N, Alani O, Patel D et al.